Lymphocytes obtained from nonimmuno deficient children treated with commercially available preparations of gammaglobulin failed to proliferate and to mature into plasma cells in vitro after stimulation with pokeweed mitogen. The influence of the treatment on lymphocyte functions varied according to the cell population considered. A T helper cell activity was detected in these patients but only in the cell subset bearing receptors for IgG after irradiation. T lymphocytes exerted a suppressive effect that disappeared after irradiation or incubation at 37°C. The suppressive cells were found among E rosetteforming cells depleted of leukocytes bearing receptors for IgG. Their suppressive effect was expressed only in the presence of normal radioresistant T lymphocytes that did not bear Fc receptors for IgG. Similar dysfunctions could be induced in vitro by incubation of normal T and B lymphocytes with gammaglobulin preparations. Because F(ab)¢2 fragments or deaggregated preparations of gammaglobulin failed to activate T suppressor lymphocytes, this activation was likely triggered by attachment of Fc portion of denatured IgG to the corresponding membrane receptor. This activation step was prostaglandin E 2 -dependent, suggesting that activated monocytes were involved in the activation process. B lymphocyte responses appeared directly inhibited by attachment of denatured gammaglobulin on membrane Fc receptor. Our observations suggest that immunological effects of gammaglobulin therapy are not limited to antibody transfer, since it also induces subtle modifications […] 
. Suppressor ftinctions have been ascribed predominantly to T lymphocytes activated either by fixation of immune complexes on Fc receptors for IgG (Fcy) (5) or by mitogens, such as concanavalin A (Con A) (4, (7) (8) (9) (10) . Other suppressor leukocytes have been described including B lymphocytes (11) and monocytes (12) (13) (14) (15) acting through the release of suppressor mediators, especially prostaglandin E2 (PGE2)' (13) (14) (15) (16) . Cell-to-cell interactions between subpopulations of T cells (2, 17) or T lymphocytes and monocytes (18) also play an important role in the expression of suppressor activities. The physiological relevance of these various immunoregulatory systems remains undetermined. In addition to these numerous studies showing that expression of suppressor activities requires an in vitro activation, naturally occurring suppressor lymphocytes have been shown to control the level of T and B immune responses (19) (20) (21) (22) (23) at such times as the neonatal period (24) (25) (26) , late pregnancy (26) , and in normal nonresponder subjects (27) . The generation of plasma cells during pokeweed mitogen (PWM)-stimulated leukocyte cultures allows the study of the balance between positive and negative regulatory functions. This technique appears to give reproducible results in autologous as well as in allogeneic systems.
As it was suggested that immunoglobulin may reduce the level of the humoral response (28) , and because an excess of suppressor activity was described in hypogammaglobulinemic patients receiving gammaglobulin (yG) therapy (29, 30) Mich.), Con A (Miles Laboratories, Yeda, Israel), PWM (Gibco Laboratories, Glasgow, Scotland) or antigens (tetanus toxoid, purified protein derivative, and CD) performed as previously described (31) were comparable to controls. 10 children were treated with plasmatic yG obtained from blood transfusion center (Centre National de Transfusion Sanguine, France), prepared by fractionation of plasmatic human yG using ethanol fractionation (32) , and adjusted to a final concentration of 165 mg/ml in a solution containing 22.5 mg/ml glycine and 0.1 mg/ml sodium mercurothiolate. Electrophoretic and immunoelectrophoretic studies showed that yG preparations contained a large proportion ofIgG and traces of IgA, IgM, and 2% albumin. As measured by radial immunodiffusion, IgG represented 155 mg/ml (94%); IgA, 1.5 mglml; IgM, 0.5 mg/ml. Sephadex G-200 (Pharmacia Fine Chemicals, Uppsala, Sweden) gel filtration pattern of the yG preparation used for therapy showed the presence of -30% of aggregates (>150,000 mol wt) (Fig. 1) . No antibody against histocompatibility antigens (A, B, and DR) was detected using 10-80 mg/ ml yG preparation in a microcytotoxicity test (33) .
Two other children were treated with placental yG (Institut M6rieux, Lyon, France). The yG preparation was eluted from placenta at pH 2.5, then fractionated by ethanol precipitation (32) , and adjusted at 165 mg/ml. It also contained aggregates (Fig. 1) . The yG preparation was injected intramuscularly every 15 d at the dosage of 80 mg/kg, resulting in a reduction of the frequency of infections. All children were investigated prior to, during (48 h after the third or the fourth injection), and after (1) (2) (3) (4) (5) (6) (7) (8) A control group consisting of healthy adult donors or agematched children was studied in parallel. All blood specimens from children were obtained following informed consent by the parents.
Leukocyte markers. Blood was collected in preservativefree heparin (100 U/ml). After dilution 1:3 in Hanks' buffer solution (Gibco Laboratories) mononuclear cells were isolated on Ficoll-Hypaque (Pharmacia Fine Chemicals) density gradient and washed twice in medium. Sheep erythrocytes forming rosettes (E-RFC) were counted as previously described (36) . A heteroantiserum specific for human T leukocyte antigen (HTLA) (Institut Merieux) was also used in a microcytotoxicity test, and results were expressed after substraction of the background. Surface immunoglobulins (slg) were detected by membrane immunofluorescence using fluorochrome-labeled monospecific F(ab)'2 fragments against human ,u-, 8-, y-, and a-chains and anti-F(ab) IgG (Nordic Laboratories, Tilburg, Netherlands) (37) . In order to detect actual products of B lymphocytes, cells were preincubated 30
Efflet volume (ml) FIGUmR 1 Elution patterns from Sephadex G-200 ofplasmatic (-----) and placental (. ) yG preparation and purified human IgG ( ): F, elution zone offerritin (mol wt, 450,000), A, elution zone ofheat-aggregated human IgG. yG preparation appears to contain -30% aggregates (mol wt > 150,000). Placental yG preparation was contaminated by a heterogeneous polypeptide (-50 ,000 mol wt) as defined by polyacrylamide gel (45) ; this constituant was precipitated by anti-IgG antiserum in double immunodiffusion and was found not to be suppressive in the PWM system. min at 37°C or treated with trypsin (ICN Pharmaceuticals Inc., Cleveland, Ohio) (2 mglml), then washed and incubated for 7 h before slg studies were performed. Detection of C3b and Fc receptors was performed by EAC (erythrocytes antibody complement) rosetting and fixation of heat-aggregated rabbit IgG revealed by a fluorescent sheep antiserum anti-rabbit IgG (38) . Ia-antigen was revealed by an anti-Ia antiserum raised in rabbit (kindly donated by Dr. P. Niaudet, Institut National de la Sant6 et de la Recherche Medicale, Paris) and prepared according to a technique previously described (39) .
Determination of E-RFC-bearing Fc receptors for IgG (EAy[+] cells) was done as described by Moretta et al. (5) .
Detection ofendogenous peroxidase was done as described by Preudhomme and Flandrin (40) . Histochemical staining for anaphthyl esterase was used to define subpopulations ofhuman blood T lymphocytes and monocytes, as described by Horwitz et al. (41) . Cell separation. E-RFC positive or E(+) and E-RFC negative or E(-) leukocytes were obtained as already described (26) . After erythrocyte lysis, preparations from controls and children who received yG-E(+) contained 85 (42) , ata final concentration 1:100, were added.
Various pretreatments of cell preparations were performed in particular experiments: pretreatment of E(-) preparations either by trypsin or by a cytotoxic anti-HTLA in the presence of complement, filtration ot E(+) or EAy(-) cells through nylon wool columns (NWC) as described by Julius et al. (43) (0.5±0.9% peroxidase positive cells were enumerated), incubation of E(+), EAy(-), or EAy(+) leukocytes during 24 h at 37°C in RPMI 1640 medium (Gibco Laboratories) containing 20% decomplemented human AB+ serum or irradiation of E(+), EAy(+), or EAy(-) cells at 2,000 rad in a gamma cell irradiator.
Elsewhere, before being cultured, control E(-), E(+), or EAy(-) leukocytes were incubated with extensively dialyzed plasmatic (batches 77 D277 A and 77 D 853 F) or placental (batch U 0 143 I) yG preparations (0.07-1.5 mg/ml).
In other experiments, control E(+) or EAyk-) cell populations were incubated with the same concentrations of aggregated or deaggregated yG(separated by gel filtration on Sephadex G-200) or of F(ab)'2 fragments of plasmatic yG(prepared by peptic digestion (pepsin, Sigma Chemical Co.) 20 h, 370C, followed by gel filtration, according to the technique of Natvig and Turner [44] ). Purity of F(ab)'2 fragments was verified on sodium dodecyl sulfate polyacrylamide gel (45) . Finally, control E(+) cell preparations were incubated with the same concentrations of plasmatic or placental yG previously absorbed (vol/vol) with a pool oftotal (times three) and E(-) (times two) normal leukocytes before testing for suppressive activity.
In all experiments, cell viability was >90% as judged by trypan blue exclusion.
Cell cultures. PWM-stimulated cultures were performed as previously described (26) . Cultured cells, harvested at day 7, were counted and stained for the presence of intracytoplasmic immunoglobulin with fluorescent monospecific anti-heavy chain (N. L. Cappel Laboratories, Inc., Cochranville, Pa.) or polyvalent anti-human immunoglobulin (Meloy Laboratories, Inc., Springfield, Va.) antisera. The proportion of immunoglobulin-bearing and immunoglobulin-containing cells (ICC, or plasma cells) was determined by examination of 500-1,000 cells. Proliferative responses, measured by incorporation of tritiated thymidine (2 ,uCi/ml, sp act 1 Ci/mM) added during the last 18 h of the culture were expressed in A-counts per minute, after subtraction of the background.
Statistical analysis. Data are expressed as the mean value ± 1 SD. The level of significance (P) was obtained using Student's t test.
RESULTS
Effect of yG injections on blood lymphocyte markers. Absolute number and expression of surface markers of T and B lymphocytes remained unchanged during yG therapy. Double staining experiments showed, however, that 25% of ,-and 8-bearing B lymphocytes were also detected by F(ab)'2 fragments of anti-y-chain antibodies. y-chains that cocapped with Ia antigens were thought unlikely to be B lymphocyte products as they did not reappear after an in vitro trypsin treatment.
Reduced capability of yG-treated children leukocytes to proliferate and to mature into ICC during a PWM-stimulated culture. Leukocytes from 10 children before therapy were capable of proliferation and maturation into ICC in the presence of PWM, comparable to adult or age-matched normal children. In contrast, leukocytes from the same children receiving plasmatic yG injections proliferated less well than normal leukocytes (P < 0.01) and demonstrated reduced plasma cell maturation (P < 0.001) ( Table I) . Studies of membrane markers indicated that the reduction of proliferation occurred in both T and B cell populations and showed that, although 8-chain determinants normally disappeared, y-and a-bearing lymphocytes were strongly diminished. The same abnormalities, absent before therapy, appeared in two children receiving yG of placental origin.
Longitudinal studies performed in six children indicated that this failure persisted several months (up to 5 mo) after cessation of yG therapy. After restoration of PWM-induced responses we observed, in three chil- (Table IV) . Such an effect was increased by a previous irradiation of E(+) leukocytes. The cell recovery and expression of sIg determinants were comparable to that of control cocultures. EAy(+) leukocytes isolated either from treated children or from control individuals were unable to allow maturation of B lymphocytes (P < 0.001), unless they were irradiated in order to abolish the suppressor activity induced by fixation of EA complexes. EAy(-) leukocytes from treated children, contrary to control EAy( -) leukocytes, were ineffective as inducers of proliferation (P < 0.02) and maturation into plasma cells of control B lymphocytes (P < 0.02), even after a 2,000-rad irradiation.
Suppressor activity of T lymphocytes from yGreceiving children or their subsets on PWM-induced T and B cell proliferation and maturation of B lymphocytes. Addition of control E(+) leukocytes to a constant number of autologous or allogeneic total control leukocytes (ratio 1:1) did not affect proliferation and maturation of B lymphocytes in presence of PWM. therapy provoked a significant inhibition of T and B cell proliferation (P < 0.001) and of B cell maturation (P < 0.001) when added to control total leukocyte cultures (Table V) (Table V) or by a preincubation (24 h 37°C) in culture medium added with normal human serum (P < 0.001) (data not shown). The suppressor activity exerted by EAy(+) leukocytes from yG-treated children and from controls were similarly sensitive to irradiation (P < 0.001) but not to a previous incubation (P > 0.5). Although, as already indicated, E(+) leukocytes from yG-treated children exerted a helper activity on B lymphocytes present in control E( -) cell preparations, the same E(+) leukocytes became able to express a suppressive activity when a small quantity of control E(+) was added to the co-cultures. The intensity of this suppressive effect was proportional to the number of added control E(+) cells (Fig. 2) . Cells present in control E(+) leukocyte preparations, and necessary for the expression of yG-treated E(+) leukocyte suppression, were isolated in EAy(-) populations (Fig. 2) and resistant to a 2,000-rad irradiation (data not shown).
Gammaglobulin-induced T and B Lymphocyte Dysfunctions
In vitro effect of yG-preparations on control leukocytes. Total control leukocytes, cultured in presence of either plasmatic or placental yG-preparation (0.15-1.5 mg/ml) used for therapy, were unable to proliferate (P < 0.001) and maturation of B lymphocytes was abolished (P < 0.001) (data not shown). In order to explain these results, separated cell populations were incubated in presence of yG before co-culturing with control E(-) or total leukocytes. The helper effect of incubated E(+) leukocytes could not be studied, however, since control E(+) leukocytes lost their helper function after a 48-h incubation in culture medium alone. As shown in Table VI , control fresh, but not preincubated or irradiated E(+) leukocytes acquired suppressor activity after 24 to 48 h (but not 1 h) incubation in presence of 0.07 to 1.5 mg/ml yG. This in vitro yG-induced suppressor activity was proportional to the dosage of yG. Cell cytotoxicity was observed over 1.5 mg/ml. Similar results were obtained when EAy(-) leukocytes were incubated with yG. Because E(+) or EAy(-) cell preparations contained few monocytes (-5%), it was possible that monocytes were involved in the observed suppressive effect. In fact, an extensive monocyte depletion of E(+) or EAy(-) leukocyte preparation on a NWC reduced the in vitro suppressive activity induced by plasmatic yG(P < 0.05). Control E(+) or EAy(-) leukocytes incubated in presence ofplasmatic yG and an anti-PGE2 antiserum, in order to inhibit PGE2 that could be secreted by yG-activated cells, did not acquire any suppressive activity (Table  VI) . In contrast, the suppression exerted by yG-activated E(+) cells was insensitive to the addition of anti-PGE2 antiserum in the test culture, suggesting that PGE2 was only required in the activation phase of TS (data not shown). On the other hand, control E(+) leukocytes did not acquire any suppressor activity when incubated with purified F(ab)'2 fragments of plasmatic yG or with plasmatic or placental -yG preparations depleted of aggregates by gel filtration. Such deaggregated yG preparations treated by heat (56°C for 60 min, then 63°C for 20 min) in order to again provoke aggregates, became capable of inducing TS lymphocyte activation. Finally, plasmatic or placental yG preparations previously absorbed with total E(-) leukocytes and adjusted at 1 mg/ml retained their ability to induce TS activity (data not shown).
Control B lymphocytes present in E(-) preparations pretreated (1-4 h) by either plasmatic or placental yG( 1 mg/ml) remained able to proliferate and to mature with the help ofcontrol, untreated T lymphocytes. However, when co-cultures were performed by mixing control irradiated E(+) leukocytes (in order to inhibit the yGinduced suppressive effect) and control E(-) leukocytes in presence of PWM and yG(1 mglml), proliferation (P < 0.01) and maturation of B lymphocytes (P < 0.001) were profoundly diminished. The suppressor effect ofyG when present during the culture period was still observed when anti-PGE2 substances (indomethacin or anti-PGE2 antiserum) were added in order to prevent a possible indirect PGE2-dependent suppression of B cell maturation (data not shown).
DISCUSSION
Repeated intramuscular injections of plasmatic or placental yG to 12 nonimmunodeficient children provoked a marked reduction of in vitro PWM-induced T and B lymphocyte proliferations and B lymphocyte maturation into plasma cells, an effect that persisted several months after cessation of therapy. This failure appears to be the consequence of an in vivo-induced dysregulation of both T and B cell functions.
Firstly, B lymphocytes present in E(-) leukocyte preparations responded poorly to a helper effect exerted by control or autologous T lymphocytes. Such an inability could be due either to an indirect effect, in relation to a suppressive activity exerted by monocytes, by the few T lymphocytes present in E(-) cell preparations, or to a direct inhibition of B lymphocytes. Indeed, it is well-known that activated monocytes are able to suppress lymphocyte proliferation (6, 11, 12) and B cell maturation (13, 14) . However, depletion of monocytes from yG-treated children E(-) cell preparations or their replacement by normal monocytes did not improve B lymphocyte maturation. On the other hand, depletion of T lymphocytes of low affinity for sheep erythrocytes, which have been described as suppressor for the PWMdriven B lymphocyte maturation even in a normal situation (3, 27) (20, 21, 26, 48) . In an attempt to further characterize in vivo yG-induced suppressor leukocytes, the respective activities of EAy( +) and EAy( -) populations were studied. EAy(+) leukocytes from treated patients exerted a suppressor effect on B lymphocyte maturation but not on proliferation, an effect that appeared to be radiosensitive but resistant to a 24-h preincubation, as already described for normal individual EAy(+) (5, 26 (9, 10, 26) .
'yG-induced TS activity appeared to be dependent on a cell-to-cell interaction. Indeed, the yG-induced suppression was only expressed in the presence of a normal, radioresistant, Fcy( -) subset. (55) . Monocytes could be responsible for the in vitro PGE2-induced TS activation, since activated monocytes were shown to produce large amounts of PGE2 (56) .
The exact mechanism of the in vivo and in vitro activation of TS lymphocytes is questionable. Anti-Ia antibodies that could be present in yG preparations might be responsible for the TS activation. Although anti-HLA, including anti-Ia antibodies were not detected in plasmatic yG preparations using a microcytotoxicity test, we performed absorption experiments in order to reduce the level of anti-Ia antibodies that might have not been detected by such an assay. Under our conditions ofabsorption, we failed to remove the induction of TS activity. We also showed that F(ab)'2 fragments of plasmatic yG failed to induce suppressive activity indicating that the effect was dependent on the Fc portion of -yG. Finally, deaggregated yG preparation was inefficient in inducing TS activity unless it was aggregated again by heat. Altogether, these data tend to indicate that aggregated or denatured yG plays an important role in the dysregulation of the PWM responses, probably by its attachment on membrane Fcy receptor, present on B lymphocytes, monocytes, and a T lymphocyte subset (5, 38, 56) . B lymphocyte maturation could well be directly inhibited by fixation of IgG on membrane, as already described in mouse (57, 58) . The same mechanism could activate monocytes to produce large amounts of PGE2, as shown by Passwell et al. (56) . Such an activation appears, however, transitory or not detected in blood monocytes since adherent cells from yG-treated children behave like control adherent cells. The activation ofTS lymphocytes is likely to be secondary to the effect of PGE2 secreted by activated monocytes, that acts on T lymphocytes and particularly on Fcy(-) lymphocytes, as previously shown (55) . Our observation that TS activity is predominantly found in Ty(-) lymphocyte populations does not exclude, however, the possibility that Fcy(+) TS lymphocytes could have been directly activated by yG, and thus lost their Fc-y receptors as already described (59) . Finally, yG preparations inhibit helper function normally supported by Fcy(-) cell subsets. Whether this lack of helper activity was secondary to the in vivo TS activity is not demonstrated. If so, one would expect that helper function found in EAy(+) population was either insensitive to the in vivo TS functions or selected by our technical procedures.
The observation that aggregates seem to be responsible of the induced dysregulation does not exclude other possible mechanisms. Anti-Ia antibodies for instance, especially present in placental yG (60) , might well induce comparable results as described in vitro by Broder et al. (61) . Whatever the case, preparation of yG used for therapy should be depleted of aggregates as well as of anti-Ia antibodies. In the present study, we did not document any adverse effect of yG therapy despite the profound abnormalities described in the PWM system. The only in vivo modification was a return to normal of serum IgE levels in the three children who had an increased level before treatment. The absence ofother abnormalities, including influence on the level of other serum immunoglobulin classes, could in part be explained by the fact that -yGinduced TS activity was ineffective in absence of normal T lymphocytes. However, since B lymphocytes are affected by yG therapy, a longitudinal study of primary and secondary antibody formation to antigenic stimulations could reveal a possible in vivo effect on humoral function. Even if our study does not show any clear correlation between in vitro abnormalities and in vivo effects due to yG therapy, it indicates that an assay often used in the investigation ofimmune disorders can be profoundly modified during such a treatment. Although we have observed a spontaneously occurring TS lymphocyte activity in some common variable hypogammaglobulinemic patients before any yG therapy, it appears that caution should be taken in interpreting in vitro PWM dysfunction. Indeed, yG-induced immune dysregulation can mimic or amplify abnormalities due to primary physiopathological mechanisms.
